Loading...
Loading...
Clovis Oncology
CLVS today announced anticipated
development milestones and financial guidance for 2014. Clovis currently
has three clinical development programs underway, and expects to
initiate four registration studies for two of its programs during the
first half of 2014.
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
